心衰患者的远程管理PPT课件.ppt

总结 CRT已成为治疗心衰患者的重要手段，但仍有部分患者无应答 远程监护系统相比传统门诊随访模式能够及时识别患者心衰病情变化和监测 CRT治疗有效性 不断发展的远程心衰监测工具帮助临床医生早期预测心衰加重，降低患者住院率和死亡率. Sending a Strong Signal for 10 years BIOTRONIK Home Monitoring? 2009 2002 2010 2006 2003 2000 First application of BIOTRONIK Home Monitoring for technical feasibility studies New system interface with intelligent traffic light system expanded FDA and CE Mark approvals for replacement of in-clinic follow-ups and early detection Global launch as only FDA CE approved system for remote monitoring in pacemaker and ICD patients 10 years of Excellence in Home MonitoringTRUST final results published in Circulation demonstrate significant benefits of BIOTRONIK Home Monitoring Bidirectional telemetry and IEGM-Online HDSignificant increase in data volume to a follow-up equivalent including real-time online IEGMs First internet-based Home Monitoring systemInternet based service center and world’s first wireless and cellular transmitter for early detection * * * * * BIOTRONIK HM is the first and only fully wireless system on the market. With Evia we are launching the first and only pacemaker with complete, wireless remote FU capability. Why should we place emphasis on wireless? Because Evia transmits automatically wireless information to the CM II-S. Then the CM II-S is sending again wireless messages - via mobile communication – to the HM Service Center. Within minutes, complete remote FU data are provided online to the physician. Not only data for patient’s rhythm monitoring and device related information are available, beyond that a periodic IEGM online is forthcoming – the first time for pacemakers. Even more exiting, this new periodic IEGM is conform with guidelines. And last but not least, BHM has been approved by FDA EU regulatory to safely replace in-clinic follow-ups. Looking into details… * * * * * * * * * * * * * * * * * * * * * * Prognosis预后 * * * 临床观察 在CRT-D患者中，房颤时室率控制不佳是导致CRT再同步起搏比例下降的主要原因1,而后者与心衰再住院风险和全因死亡率升高相关 2. 结论 如果房颤时有